Exact Mass: 354.1304

Exact Mass Matches: 354.1304

Found 125 metabolites which its exact mass value is equals to given mass value 354.1304, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

FUSARENON X

Trichothec-9-en-8-one, 12,13-epoxy-3alpha,4beta,7beta,15-tetrahydroxy-, 4-acetate

C17H22O8 (354.1315)

D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside

Methyl 8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dec-9-en-4,6-diynoic acid

C17H22O8 (354.1315)

Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside is found in root vegetables. Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside is a constituent of Helianthus tuberosus (Jerusalem artichoke). Constituent of Helianthus tuberosus (Jerusalem artichoke). Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside is found in root vegetables.

Methyl helianthenoate F glucoside

Methyl (8Z)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dec-8-en-4,6-diynoic acid

C17H22O8 (354.1315)

Methyl helianthenoate F glucoside is found in root vegetables. Methyl helianthenoate F glucoside is a constituent of Helianthus tuberosus (Jerusalem artichoke). Constituent of Helianthus tuberosus (Jerusalem artichoke). Methyl helianthenoate F glucoside is found in root vegetables.

1,2-Bis(6-methoxy-1h-benzimidazol-2-yl)ethane-1,2-diol

1,2-bis(5-methoxy-3H-1,3-benzodiazol-2-yl)ethane-1,2-diol

C18H18N4O4 (354.1328)

Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-

C18H24Cl2N2O (354.1266)

FUSARENON X

3,10-dihydroxy-2-(hydroxymethyl)-1,5-dimethyl-4-oxo-8-oxaspiro[oxirane-2,12-tricyclo[7.2.1.0²,⁷]dodecan]-5-en-11-yl acetate

C17H22O8 (354.1315)

Isofezolac

2-(1,3,4-triphenyl-1H-pyrazol-5-yl)acetic acid

C23H18N2O2 (354.1368)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

Hydroprotopine

13-methyl-5,7,17,19-tetraoxa-13-azoniahexacyclo[11.11.0.0^{2,10.0^{4,8.0^{15,23.0^{16,20]tetracosa-2,4(8),9,15(23),16(20),21-hexaen-1-ol

C20H20NO5+ (354.1341)

D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Reference Standard (Level 1)

Fusarenon-X

CID 12309986

C17H22O8 (354.1315)

D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

Methyl helianthenoate F glucoside

methyl (8Z)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dec-8-en-4,6-diynoate

C17H22O8 (354.1315)

Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside

methyl 8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dec-9-en-4,6-diynoate

C17H22O8 (354.1315)

Z-Ala-Met-OH

C16H22N2O5S (354.1249)

Fmoc-D-Asn-OH

C19H18N2O5 (354.1216)

3-[6-(ETHOXYCARBONYL)-3-ETHYL-2-METHYL-3H-BENZIMIDAZOL-1-IUM-1-YL]PROPANE-1-SULFONATE

C16H22N2O5S (354.1249)

Trifezolac

C23H18N2O2 (354.1368)

1,3-Bisbenzyl-2-oxoimidazolidine-4,5-dicarboxylic acid

C19H18N2O5 (354.1216)

Fmoc-Gly-Gly-OH

C19H18N2O5 (354.1216)

Butyl(triphenyl)phosphonium chloride

C22H24ClP (354.1304)

4-[carboxy-(3-chloro-phenyl)-methyl]-piperazine-1-carboxylic acid tert-butyl ester hydrochloride

C17H23ClN2O4 (354.1346)

7-CHLORO-2,4-DIMETHYLQUINOLINE

C17H23ClN2O4 (354.1346)

Propanedioic acid,2-(3,4,5-trimethoxybenzoyl)-, 1,3-diethyl ester

C17H22O8 (354.1315)

cis-1,3-dibenzyl-2-oxo-4,5-imidazolidinedicarboxylic acid

C19H18N2O5 (354.1216)

Thiourea, N-(2,3-dimethylphenyl)-N-[4-(4-fluorophenyl)-5-methyl-1H-pyrazol-3-yl]- (9CI)

C19H19FN4S (354.1314)

4-Methyl 1-(2-methyl-2-propanyl) 4-[(trifluoroacetyl)amino]-1,4-p iperidinedicarboxylate

C14H21F3N2O5 (354.1402)

2-Amino-7-hydroxy-4-(3,4,5-trimethoxyphenyl)-4H-chromene-3-carbon itrile

C19H18N2O5 (354.1216)

BENZOFURAN-2-YL-[4-(4-FLUORO-PHENYL)-PIPERAZIN-1-YL]-ACETIC ACID

C20H19FN2O3 (354.138)

3-(3-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N2O5S (354.1249)

3-(4-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N2O5S (354.1249)

Fmoc-Asn-OH

C19H18N2O5 (354.1216)

2-CHLORO-3,4-BIS(PIVALOYLOXY)ACETOPHENONE

C18H23ClO5 (354.1234)

[1,1:3,1-Terphenyl]-4,4-diol,5-(4-hydroxyphenyl)-

C24H18O3 (354.1256)

(11-Bromoundecyl)(trimethoxy)silane

C14H31BrO3Si (354.1226)

Methyl 4-(4-Boc-1-piperazinyl)-2-chlorobenzoate

C17H23ClN2O4 (354.1346)

6-(Phthalimidomethyl)-6,11-dihydro-5H-dibenz-[b,e]azepine (PMDAP)

C23H18N2O2 (354.1368)

Fmoc-Asp-NH2

C19H18N2O5 (354.1216)

1-naphthylacetic anhydride

C24H18O3 (354.1256)

1-Trityl-1H-imidazole-4-carboxylic acid

C23H18N2O2 (354.1368)

N-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-N-(2-ethoxycarbonylsulfanyl-4-hydroxy-1-methyl-but-1-enyl)-formamide

C15H22N4O4S (354.1362)

fmoc-d-asp-nh2

C19H18N2O5 (354.1216)

Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate

C17H23ClN2O4 (354.1346)

2-Diphenylacetyl-1,3-indandione-1-hydrazone

C23H18N2O2 (354.1368)

Nesolicaftor

C18H18N4O4 (354.1328)

C87006 - Pharmacological Chaperone

3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzamide

C18H24Cl2N2O (354.1266)

1,2-Bis(6-methoxy-1h-benzimidazol-2-yl)ethane-1,2-diol

C18H18N4O4 (354.1328)

Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, cis-

C18H24Cl2N2O (354.1266)

D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

3-Hydroxy-6-(hydroxymethyl)-2-[(3-methoxyphenyl)-(2-pyridinylamino)methyl]-4-pyranone

C19H18N2O5 (354.1216)

2-[[3-Methyl-7-(3-methylbutyl)-2,6-dioxo-8-purinyl]thio]propanoic acid methyl ester

C15H22N4O4S (354.1362)

3-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-(3-pyridinyl)propanamide

C18H18N4O4 (354.1328)

[1-(3-Chloro-2-formyl-phenylcarbamoyl)-2-methyl-propyl]-carbamic acid tert-butyl ester

C17H23ClN2O4 (354.1346)

4-Acetylnivalenol

C17H22O8 (354.1315)

2-(3,4-Dichlorophenyl)-1-[2-(1-pyrrolidinylmethyl)-1-piperidinyl]ethanone

C18H24Cl2N2O (354.1266)

3-[(2-Amino-benzoyl)-hydrazono]-N-benzo[1,3]dioxol-5-yl-butyramide

C18H18N4O4 (354.1328)

N-[(4R)-1-(2,4-difluorophenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2-pyridinecarboxamide

C19H16F2N4O (354.1292)

N-[4-(cyanomethyl)phenyl]-4-cyclohexylbenzenesulfonamide

C20H22N2O2S (354.1402)

N-(1,3-benzodioxol-5-ylmethyl)-2-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)acetamide

C19H18N2O5 (354.1216)

2-{[3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N-[(1E)-(2-hydroxyphenyl)methylene]acetohydrazide

C18H18N4O4 (354.1328)

N-[(4S)-1-(2,4-difluorophenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2-pyridinecarboxamide

C19H16F2N4O (354.1292)

N-acetylmethionyltyrosine

C16H22N2O5S (354.1249)

2-[(2S,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)

2-[(2S,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)

2-[(2R,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)

2-[(2S,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)

2-[(2R,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)

2-[(2R,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)

3,4,5-Trihydroxy-6-[3-hydroxy-2-(3-methylbut-2-enyl)phenoxy]oxane-2-carboxylic acid

C17H22O8 (354.1315)

6-(2-Benzyl-3-oxobutoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H22O8 (354.1315)

Isofezolac

2-(2,4,5-triphenylpyrazol-3-yl)acetic acid

C23H18N2O2 (354.1368)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

ER-000444793

C23H18N2O2 (354.1368)

ER-000444793 is a potent inhibitor of mitochondrial permeability transition pore (mPTP) opening. ER-000444793 inhibits mPTP with an IC50 of 2.8?μM.

KI-7

C23H18N2O2 (354.1368)

KI-7 is an A2B adenosine receptor positive allosteric modulator. KI-7 potentiates the cAMP accumulation induced by the non-selective A2B adenosine receptor agonist NECA (EC50=445.8 nM). KI-7 also potentiates the cAMP accumulation induced by the selective A2B adenosine receptor agonist BAY 60-6583 as well as by adenosine with EC50s of 2390 nM and 2550 nM, respectively[1][2].

MLS1547

C19H19ClN4O (354.1247)

MLS1547 is a highly efficacious G protein-biased dopamine D2 receptor (D2R) agonist (Ki=1.2 μM). MLS1547 stimulates D2R G protein-mediated signaling (EC50=0.37 μM in a calcium mobilization assay). MLS1547 acts as an antagonist for dopamine (DA)-stimulated β-arrestin recruitment to the D2R (IC50=9.9 μM)[1][2].

(3s,4r)-8-hydroxy-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one

C17H22O8 (354.1315)

{8,10,11-trihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-6-yl}methyl acetate

C17H22O8 (354.1315)

(10'r,11's)-3',10'-dihydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-4'-oxo-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate

C17H22O8 (354.1315)

(2e)-8,11-dihydroxy-6-(hydroxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-10-yl acetate

C17H22O8 (354.1315)

3-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl)-3h-2-benzofuran-1-one

C17H22O8 (354.1315)

9-hydroperoxy-5,6-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate

C17H22O8 (354.1315)

[(1s,2e,8r,10r,11s)-8,10,11-trihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-6-yl]methyl acetate

C17H22O8 (354.1315)

(1's,2s,2'r,3's,7'r,9'r,10'r,11's)-3',10'-dihydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-4'-oxo-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate

C17H22O8 (354.1315)

1,2-methylenedioxy-4-methoxy-5-allyl-phen-3-yl beta-d-glucopyranoside

1,2-methylenedioxy-4-methoxy-5-allyl-phen-3-ylβ-d-glucopyranoside

C17H22O8 (354.1315)

{"Ingredient_id": "HBIN000904","Ingredient_name": "1,2-methylenedioxy-4-methoxy-5-allyl-phen-3-yl beta-d-glucopyranoside","Alias": "1,2-methylenedioxy-4-methoxy-5-allyl-phen-3-yl\u03b2-d-glucopyranoside","Ingredient_formula": "C17H22O8","Ingredient_Smile": "COC1=C(C2=C(C=C1CC=C)OCO2)C3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31609;14367","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}